An FDA panel rejected MDMA-based treatments for PTSD often used with veterans. One advocate shared what the verdict means for the future of mental health care, while doctors stressed supervision.

A US Food and Drug Administration (FDA) expert panel has found that the benefits of the psychedelic midomafetamine (MDMA) in combination with psychological intervention for the treatment of ...

The FDA declined to approve MDMA-assisted therapy, commonly known as ecstasy, as a treatment for PTSD. FDA rejects MDMA-assisted therapy for PTSD in a setback for psychedelic medicine.

FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study Drugmaker Lykos Therapeutics said the FDA notified the company that its drug “could not be approved based on data ...

FDA rejects MDMA therapy for treatment of PTSD. ... The FDA was considering an application for a treatment manufactured by the California-based biotech Lykos Therapeutics that involves intense ...

There are only two FDA-approved treatments for PTSD. MDMA would be the first to come on the market in decades. Though classified as a Schedule I drug, the FDA granted MDMA "breakthrough therapy ...

FDA advisers voted 10-1 against the overall benefits of using MDMA to treat PTSD, citing flawed study data, questionable research conduct. Advocates and scientists say those who received doses of ...

WASHINGTON (AP) — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of ...

FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study Drugmaker Lykos Therapeutics said the FDA notified the company that its drug “could not be approved based on data ...